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Abstract
Background: Early-life infection by respiratory syncytial virus (RSV) is associated with aberrant expression of the prototypical
neurotrophin nerve growth factor (NGF) and its cognate receptors in human bronchial epithelium. However, the chain of
events leading to this outcome, and its functional implications for the progression of the viral infection, has not been
elucidated. This study sought to test the hypothesis that RSV infection modulates neurotrophic pathways in human airways
by silencing the expression of specific microRNAs (miRNAs), and that this effect favors viral growth by interfering with
programmed death of infected cells.
Methodology: Human bronchial epithelial cells infected with green fluorescent protein-expressing RSV (rgRSV) were
screened with multiplex qPCR arrays, and miRNAs significantly affected by the virus were analyzed for homology with
mRNAs encoding neurotrophic factors or receptors. Mimic sequences of selected miRNAs were transfected into non-
infected bronchial cells to confirm the role of each of them in regulating neurotrophins expression at the gene and protein
level, and to study their influence on cell cycle and viral replication.
Principal Findings: RSV caused downregulation of 24 miRNAs and upregulation of 2 (p,0.01). Homology analysis of
microarray data revealed that 6 of those miRNAs exhibited a high degree of complementarity to NGF and/or one of its
cognate receptors TrKA and p75
NTR. Among the selected miRNAs, miR-221 was significantly downregulated by RSV and its
transfection in bronchial epithelial cells maximally inhibited gene and protein expression of NGF and TrKA, increased
apoptotic cell death, and reduced viral replication and infectivity.
Conclusions/Significance: Our data suggest that RSV upregulates the NGF-TrKA axis in human airways by silencing miR-221
expression, and this favors viral replication by interfering with the apoptotic death of infected cells. Consequently, the
targeted delivery of exogenous miRNAs to the airways may provide a new strategy for future antiviral therapies based on
RNA interference.
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Introduction
Respiratory syncytial virus (RSV) infection modifies the
expression of critical neurotrophic factors and receptors [1], and
this effect has important implications for the pathophysiology of
airway inflammation and hyperreactivity during and after the
acute infection [2]. In particular, we have shown previously a
significant upregulation of the nerve growth factor (NGF) and its
cognate high-affinity receptor tropomyosin-related kinase A
(TrkA), with concomitant downregulation of the low-affinity
pan-neurotrophin p75
NTR receptor [3]. As NGF prevents
apoptosis through TrkA by increasing expression of the anti-
apoptotic Bcl-2 family members, whereas p75
NTR signaling
promotes apoptosis via JNK, NF-kB and ceramide activation,
these adjustments are geared to keep the infected airway epithelial
cells alive to support RSV replication and infection with a
mechanism similar to that previously described in macrophages
infected with the human immunodeficiency virus (HIV) [4].
We have confirmed these interactions between RSV and
neurotrophic pathways in humans, showing increased NGF and
TrkA expression in the cell fractions obtained by bronchoalveolar
lavage from infants with active RSV infection [5], and we have also
localized these changes to the epithelium of the distal airways [3].
However, the exact mechanisms involved in the upregulation of
NGF expression by RSV and its functional implications for the
efficiencyand progressionoftheinfectionarestillpoorlyunderstood,
and additional knowledge in this area could result in significant
progress toward the therapy of this highly prevalent disease.
The discovery of RNA interference [6] has broadened
dramatically our understanding of the epigenetic mechanisms
regulating gene expression, and considerable attention has been
dedicated to the role of microRNA (miRNA) species [7]. Mature
miRNAs are non-coding transcripts 18 to 25 nucleotides in length
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to complementary or partially complementary messenger RNA
(mRNA) targets and priming them for degradation or translational
inhibition. In humans, the extensive regulatory network involving
.700 miRNAs, each able to target .300 different mRNAs, is
predicted to regulate .60% of coding genes [8] and has been
implicated in a wide range of fundamental cellular processes
including proliferation, differentiation, and death [9]. Further-
more, .200 miRNAs encoded by the genome of several families
of mammalian viruses have been identified.
In the present study, we tested the hypothesis that specific
miRNA species modulate the expression of key neurotrophic
factor and receptors in human bronchial epithelial cells, and are in
particular responsible for the dysregulation of neurotrophic
pathways during RSV infection. For this, human bronchial
epithelial cells infected with green fluorescent protein (GFP)-
expressing recombinant RSV (rgRSV) were screened with miRNA
microarrays, and homology search identified specific miRNA
species complimentary to NGF or its cognate receptors TrKA and
p75
NTR. Mimic sequences of the selected miRNAs were then
transfected into non-infected bronchial cells to confirm their role
in the regulation of neurotrophin expression using quantitative
real-time polymerase chain reaction (qPCR) and fluorescence
activated cell sorting (FACS). This explorative analysis allowed to
focus our attention on miR-221 for more mechanistic experiments
involving FACS and confocal microscopy to study the influence of
this miRNA on NGF expression and programmed death of
infected cells. Finally, we tested the hypothesis that synthetic
homologues of miR-221 delivered directly to the bronchial
epithelium affect RSV replication, and may therefore have
therapeutic potential against this infection.
Methods
Cells and virus
Human bronchial epithelial cells derived from the surface
epithelium of normal Caucasian or Black donors of both sexes
with ages ranging from 16 to 65 years were purchased from Cell
Applications (San Diego, CA) and were maintained at 37uC in the
proprietary growth media and supplements provided by the
vendor [3]. Each experiment was repeated using cells from
different donors throughout the study to control for host genetics
and environment.
The rgRSV stock derived from the RSV-A2 strain and
expressing the green fluorescent protein gene [10] was kindly
provided by Dr. Mark Peeples (Columbus Children Research
Institute, Columbus, OH) and Dr. Peter Collins (National
Institutes of Health, Bethesda, MD). Cultivation and harvesting
of rgRSV was performed at West Virginia University as described
previously [3]. To study miRNA expression patterns during
infection, the bronchial cells were grown in 6-well plates for 48 h
and subsequently infected for 24 h with rgRSV at multiplicity of
infection (MOI) of 1. Duration and multiplicity of infection were
chosen based on previously published studies [3]. Also, we did not
run control experiments with UV-inactivated virus because our
previous studies have shown that UV-RSV has no effect on
neurotrophins expression in airway epithelial cells [3].
miRNA analysis
miRNA expression in rgRSV-infected bronchial epithelial cells
and in non-infected controls was compared using the mirVana
TM
isolation kit (Ambion, Austin, TX) and the TaqManH MicroRNA
assay (Applied Biosystems, Foster City, CA). This multiplex
qPCR array is based on 384-well microfluidic cards [TaqManH
Low-Density Array (TLDA)] with primers and probe for each
assay preloaded and dried onto the designated duplicate wells
[11], which enables the accurate quantitation of 378 mature
human miRNAs. Mammalian U6 (MammU6), RNU44, and
RNU48 were used as endogenous housekeeping genes to aid in
data normalization. Data sets generated by Genome Explorations
(Memphis, TN) were analyzed with the software SDS version 2.3
and AB qPCR-R (Applied Biosystems). We used TargetScan and
miRBase as bioinformatics tools for target identification.
Transfection
Bronchial epithelial cells were reverse-transfected with precur-
sor (pre)-miRNA oligonucleotides using the lipid-based siPORT
NeoFX
TM reagent diluted in Opti-MEMH I reduced serum
medium (Gibco, Grand Island, NY) according to the protocol
provided by the manufacturer (Ambion). Briefly, cells in their early
passages (passage 2 or 3) were trypsinized and counted.
Transfection complexes were directly applied to the cells (50,000
cells/well in 6-well plates) to reach a final pre-miRNA oligonu-
cleotide concentration of 50 nM, and the plates were incubated in
a humidified chamber with 5% CO2 at 37uC for 24 h. Control
cells were transfected with the Pre-miR
TM negative control
provided by the same vendor. To study the effects of selected
miRNAs in the context of viral infection, cells surviving 48 h after
transfection were incubated with rgRSV at MOI of 1. After 6 h of
infection, the excess virus was washed off and fresh growth
medium was added. Cells were then incubated for another 18 h
(i.e., a total of 72 h after starting the transfection). At the end of the
incubation, cells were harvested by trypsinization, washed with
PBS, and used for further analysis.
qPCR
Total RNA was isolated from bronchial epithelial cells using the
RNeasy kit (Qiagen, Valencia, CA) and 100 ng per reaction was
used for qPCR analysis using the SYBR green one-step RT-PCR
master mix (Qiagen) and the ABI 7500 real-time cycler (Applied
Biosystems). NGF, TrKA, and p75
NTR primers were purchased
from SABiosciences (Rockville, MD). Transcript expression was
normalized using hypoxanthine phosphoribosyltransferase 1
(HPRT1; RealTimePrimers, Elkins Park, PA) as the housekeeping
gene. Relative change in gene expression was calculated using the
formula: fold change=2‘2(ddCt)=2-dCt (treated samples)2dCt
(control samples), where dCt=Ct (detected gene)2Ct (HPRT1)
and Ct is the threshold number. Cycle threshold (Ct) values were
calculated with the SDS software using automatic baseline settings
with assigned minimum threshold of 0.2. Because the Ct value of
35 represents single template detection, Ct values .35 were
considered to be below the detection level of the assay.
FACS
Bronchial epithelial cells were isolated by trypsinization and
stained with specific antibodies for intracellular and surface
detection of NGF, TrKA, and p75
NTR (Santa Cruz Biotechnology,
Santa Cruz, CA). Rabbit IgG (Southern Biotechnology, Birming-
ham, AL) was used as isotype control for non-specific binding.
Secondary antibodies were labeled with Alexa 488 and Alexa 546
(Invitrogen, Carlsbad, CA). Data were acquired using a FACS-
Calibur instrument (BD Biosciences, Franklin Lakes, NJ) and
analyzed with the software Windows Multiple Document Interface
version 2.9 for flow cytometry (WinMDI, La Jolla, CA).
To detect rgRSV infection, the cells were trypsinized, fixed with
1% formaldehyde for 20 min, centrifuged and resuspended in
PBS, and analyzed using FACSCalibur. A minimum of 10,000
events were collected per sample. Non-infected cells were used to
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(488 nm for excitation and 515–545 nm for GFP detection). Once
background fluorescence was established, a marker was drawn such
that ,1% of non-infected cells were considered positive. Mean
fluorescent intensity was calculated using the WinMDI software.
Cell death
Non-infected and rgRSV-infected bronchial epithelial cells were
transfected with 50 nM of pre-miR-221 or with the negative
control miRNA. Cells were harvested 48 h later, resuspended in
100 mlo f1 6annexin binding buffer, and stained for 10 min with
5 ml of annexin V-PE (MBL International, Woburn, MA) and 5 ml
of propidium iodide (PI; BD Biosciences, San Jose, CA) to detect
apoptosis and necrosis, respectively. After adding 400 mlo f1 6
buffer to each sample, flow cytometry analysis was performed
using a FACSCalibur instrument.
Virus titration
rgRSV titration was performed as described previously [12].
Briefly, serial dilutions of each sample were prepared in culture
medium and 50 ml of the each dilution was inoculated in duplicate
on sterile 96-well plates of bronchial cells. After 24 h incubation,
the cells were observed under a fluorescent microscope for green
fluorescence (EVOS, Advanced Microscopy Group, Bothell, WA).
Virus titer was calculated using the following formula: (number of
infectious units)6(1/dilution)/(volume of inoculum). Since this
assay tests for infection and production of GFP rather than virus
spread and plaque formation, this infectivity assay is more
accurate than a titer determined by plaque assay.
Confocal microscopy
As described previously [3], cells transfected with the precursor
of miR-221 or with the negative control miRNA were stained for
1 h with rabbit anti-human NGF antibody (Santa Cruz Biotech-
nology), followed by a secondary PE-conjugated donkey anti-
rabbit antibody (Invitrogen) for another hour, and then were
incubated with rgRSV at MOI of 1 for 24 h. The nuclei were
stained with TOPRO-3 (Invitrogen). The glass slides were
mounted with Prolong Gold anti-fade reagent (Invitrogen) and
protected with cover slips. Images were obtained using a Zeiss
LSM510 confocal microscope with the AxioImager Z1 system
(Carl Zeiss, Jena, Germany).
Statistical analysis
All data are expressed as the mean 6 SEM. Data from qPCR
experiments are the average of 3 or 4 independent assays
performed in duplicate. False discovery rate (FDR)-corrected p-
values were calculated with the Benjamini-Hochberg method, and
were all ,0.1 [13]. Geometric mean fluorescent intensity (MFI)
was averaged from the flow cytometry measurements obtained in
3 or 4 independent experiments. The Kruskal-Wallis one-way
analysis of variance was used to analyze the effects of different
miRNAs on neurotrophins expression, and post-hoc pairwise
multiple comparisons between means were performed using the
Student-Newman-Keuls method with the statistical significance
threshold set at p,0.01. The paired Student’s t test was used to
analyze differences between rgRSV-infected cells transfected with
miR-221 vs. negative control miRNA. Statistical analysis was
performed using the software SigmaStat version 3.5 for Windows
(Systat Software, Point Richmond, CA).
Results
Microarray analysis of human bronchial epithelial cells detected
significant changes in the global profile of miRNA expression after
infection with rgRSV. Specifically, at the p,0.05 level of statistical
significance 104 miRNAs were differentially expressed between
RSV-infected cells and non-infected controls, of which 101 were
significantly downregulated and 3 upregulated. At the p,0.01
level of statistical significance, 24 miRNAs were downregulated
and 2 miRNAs were upregulated. The heat map in Figure 1
provides an overall picture of the impact of RSV infection on the
human bronchial epithelial cell miRNAome as compared to non-
infected control cells, with the cutoff level of statistical significance
set at p,0.01 in order to reduce clutter.
From this dataset, we identified 6 Homo sapiens (hsa)-miRNAs
targets that were significantly affected by RSV and were also
holding a high degree of homology to the mRNA sequences
encoding neurotrophic factors or receptors: miR-27a, miR-221,
miR-339-5p, miR-453, miR-574, and miR-744 (Table 1). We also
included in our analysis the maximally downregulated miR-331-
5p, even though it did not appear to be involved directly in the
expression of any neurotrophin. Mimic oligonucleotides of the
precursors for each of these miRNAs were transfected into non-
infected human bronchial epithelial cells to screen their individual
role in the modulation of neurotrophins expression at the gene and
protein level.
Gene expression analysis of non-infected bronchial cells by
qPCR (Figure 2) showed maximal downregulation of both NGF
and its high-affinity TrKA receptor in cells overexpressing miR-
221. In contrast, the low-affinity p75
NTR receptor gene was not
affected by miR-221, but was downregulated by miR-453 and
upregulated by miR-574. Flow cytometry analysis (Figure 3) con-
firmed the anti-neurotrophic activity of miR-221, as non-infected
Figure 1. RSV-induced change in microRNAs expression. This
heat map was generated using differentially expressed genes based on
unadjusted t-test p-values, and provides an overall picture of the
impact of RSV infection on the human bronchial epithelial cell
miRNAome as compared to non-infected control cells. Data were
partitioned between RSV and control (CTL) samples during the
hierarchical clustering and organized into blocks of columns. The rows
represent wells in each of the plates, and within each row the green
shaded areas indicate lower expression of the specific miRNA noted on
the right, whereas the red shaded areas indicate higher expression.
Black and darkly shaded areas indicate relatively similar expression
between infected and non-infected cells. The Euclidean clustering
method was used for array data analysis, and the cutoff level of
statistical significance was set at p,0.01 to reduce clutter. The
expression index is shown in the right lower corner.
doi:10.1371/journal.pone.0030030.g001
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mally reduced levels of both NGF and TrKA protein compared to
those transfected with the negative control miRNA. Also, NGF
protein was upregulated by miR-574 and TrKA was downregu-
lated by miR-331.
Based on the combined analysis of qPCR and FACS data, we
focused our attention on miR-221 to further study the role of the
NGF-TrKA axis in the regulation of programmed cell death and
viral replication. Cells overexpressing miR-221 were characterized
by important changes in programmed death. Non-infected cells
transfected with miR-221 (Figure 4A) were more prone to
apoptosis (43%) compared to cells transfected with the negative
control miRNA (8%). Furthermore, only 47% of the miR-221-
overexpressing cells survived, compared to 82% of cells transfected
with the negative control. In contrast, the proportion of necrotic
cells did not change after transfection with miRNA-221 compared
to the negative control (10.4 vs. 9.8). More importantly, 59% of
miR-221-transfected cells became apoptotic after infection with
rgRSV (Figure 4B), compared to only 22% of the infected cells
transfected with negative control miRNA.
Table 1. RSV-induced Changes in the Expression of MicroRNAs Predicted to Target Neurotrophic Pathways.
MicroRNA Relevant Target Gene Relevant Target Function Fold Change P-value
hsa-miR-331-5p AIP1 Apoptosis 23.805 ,0.05
hsa-miR-744 NGF receptor NGF binding 3.02 ,0.05
hsa-miR-453 TrKA, p75
NTR NGF binding 22.012 ,0.05
hsa-miR-221 ITGB3, NGF, NGF receptor NGF expression and binding 21.99 ,0.01
hsa-miR-27a p75
NTR, VEGF-C NGF binding, angiogenesis 21.65 ,0.01
hsa-miR-339-5p TrKB, APAF1 TrKB-BDNF binding, apoptosis 21.093 ,0.01
hsa-miR-574 NGF NGF gene expression 20.5 ,0.05
Definition of abbreviations: hsa: Homo sapiens; AIP1: apoptosis inducing protein 1; NGF: nerve growth factor; TrK: tropomyosin-related kinase; ITGB3: integrin beta 3;
VEGF-C: vascular endothelial growth factor C; APAF1: apoptotic peptidase activating factor 1; BDNF: brain-derived neurotrophic factor.
Note: Negative values represent downregulation.
doi:10.1371/journal.pone.0030030.t001
Figure 2. Gene expression in bronchial cells transfected with microRNAs. Homo sapiens (hsa)-miRNAs with a high degree of homology to
mRNAs encoding neurotrophic factors or receptors were selected from our microarray dataset, and mimic oligonucleotides of the precursors for each
of these miRNAs were transfected into human bronchial epithelial cells to study their individual role in modulating neurotrophin expression. PCR
measured maximally reduced concentrations of both NGF and TrKA transcripts in bronchial epithelial cells overexpressing miR-221. Data are
expressed as the mean 6 SEM (n=3–4 per group). *=p,0.01 compared to cells transfected with the negative control miRNA.
doi:10.1371/journal.pone.0030030.g002
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with miR-221 and then infected for 24 h with rgRSV at MOI of 1
(Figure 5) confirmed a significantly lower NGF protein expression
compared to rgRSV-infected cells transfected with the negative
control miRNA. The combined effect of miR-221 on NGF
expression and RSV replication was visualized by confocal
microscopy of bronchial epithelial cells incubated for 24 h with
rgRSV (Figure 6). Most of the bronchial epithelial cells transfected
with negative control miRNA showed strong green fluorescence as
a result of active rgRSV infection overlapping the red fluorescence
generated by concomitant overexpression of PE-labeled NGF. In
contrast, NGF expression was silenced in bronchial cells
transfected with miR-221, and this was associated with a sharp
reduction in the proportion of infected cells.
Consistently, the number of rgRSV-infected bronchial cells
counted by FACS was reduced strongly by the transfection of
miR-221 (Figure 7A), and even stronger inhibition was measured
in separate experiments by titration of the fluorescent virus
(Figure 7B). None of the other miRNAs tested in this study was
found to have any measurable effect on RSV replication (data not
shown).
Discussion
This study shows for the first time that RSV infection of the
human airway epithelium has profound effects on the pattern of
miRNAs expression in host cells, with potentially important
repercussions on the biosynthesis of key neurotrophic factors and
receptors, programmed cell death, and viral replication. Of
particular significance is the inhibitory effect exerted by this virus
on miR-221, a miRNA predicted to target for degradation the
mRNA transcripts encoding the anti-apoptotic neurotrophin NGF
and its cognate high-affinity receptor TrKA. Accordingly, our data
show that high intracellular levels of miR-221 reduce NGF
expression, favor the apoptotic death of infected cells, and limit the
infection significantly.
The model emerging from this study suggests that RSV removes
a physiologic inhibitory control exerted by miR-221 on the NGF-
TrKA pathway. By upregulating this pathway, the invading virus
prevents apoptosis and keeps the infected cells alive to allow
completion of its life cycle and establish lytic cycles of replication
that result in propagation of the infection to the neighboring cells.
Hence, our data propose miR-221 as an early regulator of RSV
replication in the bronchial epithelium, upstream from the
neurotrophic mechanisms described in our previous work [3]. As
the transcripts for both NGF and TrKA were significantly reduced
in cells overexpressing miR-221, it is more likely that these mRNA
targets are primed for degradation, rather than translational
inhibition. It also plausible that, in addition to the ones described
in the present study, other mechanistic pathways might contribute
to the control of neurotrophic pathways and modulation of virus-
induced apoptosis. As an example, miR-331 slightly downregu-
lated NGF protein levels, suggesting inhibition at the translational
level; this may be evidence of a tandem downregulation of NGF by
miR-221 transcriptionally and miR-331 translationally.
Although we were not able to procure cells from infants or
young children for our in vitro studies, the present results are
consistent and provide an explanation for the previously reported
increase of NGF and TrKA expression in cells obtained by
bronchoalveolar lavage (BAL) from human infants with RSV
bronchiolitis [5]. Of importance, the information obtained with
our in vitro experiments about the role of miRNAs in infected
bronchial epithelial cells would be impossible to find using BAL or
other clinical specimens, because the presence of extracellular
miRNAs and multiple structural and inflammatory cell types from
upper and lower airways, each having different miRNA expression
patterns, would make it very difficult to identify the cellular origin
and function of individual miRNAs.
Neurotrophins
NGF is the prototypical member of a family of neurotrophic
factors that includes the brain-derived neurotrophic factor (BDNF)
Figure 3. Flow cytometry of bronchial cells transfected with microRNAs. Consistent with the gene expression data, miR-221 transfection
was associated to maximal downregulation of NGF protein synthesis, and was also associated to maximal downregulation of its high-affinity TrKA
receptor. Data are expressed as the mean 6 SEM. Geometric mean fluorescent intensity (MFI) was averaged from the flow cytometry measurements
obtained in 3 or 4 independent experiments. *=p,0.01 compared to cells transfected with the negative control miRNA [control(-ve)].
doi:10.1371/journal.pone.0030030.g003
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aspects of neuronal cells life like survival, proliferation, differen-
tiation, neurite growth, and neurotransmission [14,15]. Two types
of membrane receptors mediate neurotrophic signaling: a) the
three members of the TrK family of receptor tyrosine kinases
TrKA, TrKB and TrKC, which exhibit selectivity for NGF,
BDNF/NT4, and NT3, respectively; and b) the p75
NTR receptor,
which is a member of the tumor necrosis factor (TNF) receptor
superfamily and binds at low affinity all four neurotrophins, but
can also bind at high affinity the NGF precursor (pro-NGF) and
regulate the affinity of TrKA for its cognate ligand.
In addition to its neurotrophic functions, NGF participates in a
number of other fundamental biological mechanisms that are
highly preserved across species. In particular, by binding its TrKA
receptor NGF modulates the activity of multiple non-neural cells
involved in immune and inflammatory responses [2] and prevents
apoptotic death of cells invaded by biological [3,4] or physical
[16,17] agents. Therefore, the NGF-TrKA axis serves as an innate
protective system that allows airway epithelial cells exposed to
airborne threats to tolerate, and maybe even exploit, potentially
pathogenetic agents. On the other hand, the anti-apoptotic activity
of NGF may also, especially in conditions of relative immunolog-
ical weakness, allow the persistence and/or propagation of the
invading agent as shown with the human immunodeficiency virus
(HIV) infection [4].
MicroRNAs
Epigenetics was originally defined as ‘‘the causal interactions
between genes and their products, which bring the phenotype into
being’’ [18] and continues to evolve to include different patterns of
DNA and RNA activity that do not depend on the genome
nucleotide sequence, such as the regulation of gene expression by
non-coding RNAs. Our data showing the involvement of miR-221
in the regulation of RSV replication provide the first evidence, to
our knowledge, of an epigenetic mechanism capable of directing
the fate of this highly prevalent respiratory infection.
Figure 4. Programmed death of RSV-infected cells. (A) Non-infected cells transfected with hsa-miR-221 were more prone to apoptosis
detected by annexin V staining compared to cells transfected with the negative control miRNA. In contrast, hsa-miR-221 transfection did not change
the proportion of necrotic cells detected by propidium iodide (PI) staining. (B) After infection with rgRSV, approximately 3 times more hsa-miR-221-
transfected cells became apoptotic compared to cells transfected with negative control miRNA. Left upper quadrant=necrotic cells; left lower
quadrant=viable cells; right lower quadrant=apoptotic cells; right upper quadrant=late apoptotic cells in necrotic state.
doi:10.1371/journal.pone.0030030.g004
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epithelial cells 24 h after infection with rgRSV showed significantly lower expression of NGF protein compared to infected cells with normal miR-221
expression. The gray population represents the isotype control. (B) Geometric mean fluorescent intensity (MFI) was averaged from the flow cytometry
measurements obtained in 3 or 4 independent experiments. Data are expressed as the mean 6 SEM. *=p,0.01 compared to cells transfected with
the negative control miRNA.
doi:10.1371/journal.pone.0030030.g005
Figure 6. Confocal microscopy of RSV-infected cells. After 24 h infection with rgRSV, most of the bronchial epithelial cells transfected with
negative control miRNA (top panels) showed strong green fluorescence as a result of active rgRSV infection and concomitant red fluorescence
upregulation of NGF expression. In contrast, NGF expression was silenced in bronchial epithelial cells overexpressing hsa-miR-221 (bottom panels),
and this effect was associated with a sharp reduction in the number of cells displaying green fluorescence. Bar scale=20 mm.
doi:10.1371/journal.pone.0030030.g006
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RNAs whose biogenesis starts with a large primary transcript (pri-
miRNA), which is processed in the nucleus by a Drosha family
member into a precursor hairpin (pre-miRNA) of 60–70
nucleotides. The Dicer enzyme further trims the precursor into
a double-stranded RNA, typically 22 nucleotides in length. The
functional strand from this duplex (mature miRNA) is incorpo-
rated into an RNA-induced silencing complex (RISC) that
invariably contains a member of the Argonaute protein family.
The active RISC is directed toward its mRNA targets to regulate,
usually negatively, the translation of the message.
Each miRNA is able to target the translation of hundreds of
partially complimentary mRNA transcripts, and can also alter
gene transcription by targeting transcription factors and DNA
methyltransferases. Therefore the resulting biological activity of
individual miRNAs is not easily predictable. In fact, the
complexity of this regulatory network may explain some
unexpected results of our experiments, like a net increase in
NGF expression following overexpression of a miRNA predicted
to target the same gene (e.g., miR-574), or measurable inhibitory
effects by miRNAs whose sequence shows no obvious homology
with any neurotrophic gene (e.g., miR-331).
MiR-221 is highly conserved in vertebrates, is encoded on the
same chromosome across species, and has a high degree of
homology to the mRNAs encoding NGF (62%) and its TrKA
receptor (68%). It has also been shown to be upregulated in some
cancer cell lines [19] and to function as an oncogenic factor by
targeting the cyclin-dependent kinase inhibitor p27Kip1
[20,21,22]; together, these observations suggest an important role
of miR-221 in cell growth regulation. Based on our findings, we
speculate that miR-221 may play a role in modulating severity and
duration of acute bronchiolitis, and possibly its chronic sequelae
like post-viral asthma. An important corollary of this hypothesis is
that exogenous administration of synthetic miRNAs may antag-
onize RSV replication in its natural target, i.e., the distal airway
epithelium, and therefore provide a novel strategy for the therapy
of this common infection.
In this study, we focused our attention on miR-221 because: 1.
It is significantly downregulated by RSV; 2. Its overexpression is
associated with maximal downregulation of NGF and its TrKA
receptor both at the mRNA and protein level; and 3. Cells
transfected with this miRNA are less prone to RSV infection.
However, our data also show significant RSV-induced changes in
other miRNAs able to modify the expression of neurotrophic
factors and receptors (e.g., miR-574, miR-453), which may also
have biological significance and therapeutic potential. Further-
more, it is quite possible that other not yet identified or
characterized miRNAs exist that either directly or via more
complex epigenetic mechanisms affect neurotrophic pathways,
programmed cell death and viral replication.
Depending on the kinetics of viral replication, miRNA patterns
expressed by infected cells can influence the ability of the invading
virus to replicate and spread [23]. On the other hand, several
viruses (especially herpesviruses and other nuclear DNA viruses)
also encode their own miRNAs that can alter or saturate the
miRNA composition of host cells [24]. Thus, both the virus and
the host are able to manipulate the miRNAome as part of their
evolutionary strategies for survival [25], and in fact several studies
have shown the involvement of both virus-encoded and cell-
encoded miRNAs in prolonging host cell survival, evading
immune recognition, and establishing viral latency [24,26]. It
should be noted, however, that the biosynthesis of virus-encoded
Figure 7. Anti-viral effect of miR-221. (A) FACS showed that hsa-miR-221 transfection reduces significantly the number of rgRSV-infected
bronchial cells compared to control cells with normal hsa-miR-221 expression. Geometric mean fluorescent intensity (MFI) was averaged from the
flow cytometry measurements obtained in 3 independent experiments. (B) Even stronger inhibition was measured in separate experiments by the
titration of fluorescent virus infectious units per ml (IU/ml; n=6 per group). Data are expressed as the mean 6 SEM. **=p,0.01 compared to cells
transfected with the negative control miRNA.
doi:10.1371/journal.pone.0030030.g007
MicroRNAs Modulate RSV Infection
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30030miRNAs is virtually impossible in RSV-infected cells, as the life
cycle of this virus is exclusively cytoplasmatic and implies lack of
access to the nuclear Drosha enzymes [27].
The experimental strategy adopted in this study, involving the
direct exposure of bronchial cells to mimic oligonucleotides -
rather than antagomirs - to define the role of specific miRNAs in
infected cells, was chosen because RSV itself acts like an
antagomir, and therefore it would have been difficult to discern
the individual effect of synthetic antagomirs in infected cells and
dissect additive or synergistic interactions. A potential shortcoming
of this approach, however, is that miRNA mimics are subject to
off-target effects and the effect seen with a mimic can be increased
as compared to an inhibitor.
Another important reason for using mimics was that we wanted
to build on a recent randomized, double-blind, placebo-controlled
clinical trial that demonstrated feasibility, safety, and potential
efficacy of a small inhibitory RNA (siRNA) complimentary to the
mRNA encoding the RSV N protein and delivered directly to the
airway mucosa by nebulization [28]. The accompanying editorial
listed among the limitation of this approach the specificity to a
single viral target, with consequent lack of activity towards co-
infecting pathogens, and the possible activation of innate
immunity by exogenous siRNAs [29]. Both of these shortcomings
could be addressed with the use of oligonucleotide mimic
sequences of endogenous miRNA species physiologically involved
in fundamental protective mechanisms like programmed cell
death, which are essential for the innate defense of the host against
a variety of invading pathogens.
In conclusions, our data show that RSV infection modifies
miRNA expression patterns in its natural target, i.e., the human
bronchial epithelium. In particular, this virus inhibits the
endogenous expression of miR-221, which is highly complemen-
tary to the mRNAs encoding NGF and its cognate receptor TrKA
and can target them for degradation. These observations suggest
that, once the physiologic silencing of the anti-apoptotic NGF-
TrKA axis is removed, the resulting inhibition of programmed
death in the infected cells may favor lytic cycles of viral replication
and spreading of infecting virions to neighboring cells. Thus, the
present study provides the proof of concept that miRNAs are
intimately involved in the intracellular mechanisms controlling
RSV replication and can be manipulated pharmacologically for
therapeutic purposes.
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